Aug 2026· International Journal of Cancer· 0 citations· 44 references
Medicine
TL;DR
CRCI may occur during certain types of chemotherapy but appears to ameliorate over time, and Ongoing endocrine therapy may have longer-lasting impact on cognitive function.
Abstract
Cancer survivors frequently experience cancer-related cognitive impairment (CRCI), but the contributions of different anti-cancer therapies remain unclear. Patients with breast or gynaecological cancer were recruited before any anti-cancer treatment. Cognitive function was assessed by objective and subjective measures pre-treatment (T0), post-treatment (T1), and 1 year after T1 (T2). Objective measures include Hopkins Verbal Learning Test-Revised (HVLT-R), Trail Making Test (TMT), Controlled Oral Word Association Test (COWA), and Mnemonic Similarity Task (MST). Subjective measures include Functional Assessment of Cancer Therapy-Cognitive scale (FACT-Cog) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Linear mixed models were performed. Patients (n = 234) were of age 55.4 ± 11.6 years. At T1, chemotherapy was associated with worse visual searching and motor speed (TMT-A: β = 0.36, 95% CI: 0.03-0.69), perceived global function (FACT-Cog Global Function: β = -0.39, 95% CI: -0.67 to -0.11), and cognitive function (EORTC QLQ-C30: β = -0.50, 95% CI: -0.82 to -0.18) compared to endocrine therapy. At T2, endocrine therapy was associated with poorer verbal learning and memory performance (HVLT-R total recall: β = -0.40, 95% CI: -6 to -0.03) and higher perceived cognitive impairments (FACT-Cog PCI: β = 0.34, 95% CI: 0.05-0.63). In conclusion, CRCI may occur during certain types of chemotherapy but appears to ameliorate over time. Ongoing endocrine therapy may have longer-lasting impact on cognitive function. Appropriate counselling for informed decision making and good supportive care is needed.
Background: Chemotherapy-induced cognitive impairment (CICI) is a well-established side-effect of cancer treatment, which can impact memory, attention, executive function and quality of life. There have been reports of cognitive impairment in chemotherapy-treated patients, but there is limited data in the Indian popula...
Vaishnavi Prasannan, Joseph Joseph, Sibu S. Teli et al.· International Journal of Res...· 0 citations
Background: Chemotherapy is a key treatment modality for solid tumors but is often associated with cognitive impairment, depression, and reduced quality of life. Early identification of these complications is important for improving patient outcomes and treatment adherence.
Methods: A prospective cohort study was condu...
Jenanee Velayutham, Jayasutha Jayram, A. Vengadeswaran et al.· International Journal of Bas...· 0 citations
Comorbid symptoms were the most common, followed by insomnia, followed by pain, anxiety, anxiety, and depression, and higher CSS was significantly associated with worse subjective CRCI after adjustment for age and chemotherapy.
Xiao-Tong Li, K. Lampson, Kevin T. Liou et al.· Breast Cancer Research and T...· 0 citations
Abstract Background Life expectancy for cancer patients has improved due to new therapies, but many survivors experience long-lasting side effects, including cancer-related cognitive impairment (CRCI). CRCI symptoms—such as difficulties with attention, memory, processing speed, fatigue, and concentration—can persist fo...
A. Benelli, Julianne Reilly, Jorge Ortega-Márquez et al.· The Oncologist· 0 citations